How The Merck-Johnson & Johnson Collaboration Could Factor Into The Global Vaccination Effort
The Biden administration announced a collaboration on Tuesday between two competitors: Merck will help produce the newly authorized single-dose Johnson & Johnson vaccine.
Here & Now‘s Callum Borchers speaks with Brook Baker, professor at Northeastern University School of Law with a focus on intellectual property and access to medicine.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org.